ArticleCancer management and research2025

Xingxiao Pill Suppressed the Progression of Non-Small Cell Lung Cancer by Targeting SREBP1/FASN-Induced Fatty Acid Biosynthesis via PI3K/AKT/mTOR Signaling Pathway.

Xiangnan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.